Karen Pignet-Aiach founded Lysogene SA and International Rare Diseases Research Consortium. Presently, she is Chairman & Chief Executive Officer of Lysogene SA and Chairman & President at Lysogene Us, Inc. (a subsidiary of Lysogene SA).
She is also on the board of France Biotex SAS.
In the past she occupied the position of Chairman of Vestingene SAS, Chairman of Kga SAS, Executive Member at International Rare Diseases Research Consortium, Member-French Ethical Review Board at Ambroise Pare Hospital, Treasurer for Alliance Sanfilippo and Treasurer of EURORDIS.
Karen Pignet-Aiach received an undergraduate degree from Université Paris 8 Vincennes Saint-Denis and an undergraduate degree from ESSEC Business School.